Corcept Therapeutics Incorporated (CORT) Q3 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari — CFO Joseph Belanoff — CEO Sean Maduck — President of Endocrinology Bill Guyer — Chief Development Officer Analysts: Charlie Robb — Corcept Therapeutics […]
The post Corcept Therapeutics Incorporated (CORT) Q3 2022 Earnings Call Transcript first appeared on AlphaStreet.